ANUCARE 107.5/18.8/12.5MG/G OINTMENT

Indications

• Skin conditions (e.g., eczema, dermatitis)
• Respiratory issues (e.g., cough, cold)
• Topical antiseptic applications
• Aromatic uses for mood enhancement

Dosage

Children: Refer to relevant product-specific guidelines as doses may vary by formulation and use.

Adults: Refer to relevant product-specific guidelines as doses may vary by formulation and use.

Mechanism of action

Balsam exerts its effects primarily through its volatile compounds, which may exhibit anti-inflammatory, antiseptic, and analgesic properties. The specific pathways are not well-characterized in modern pharmacology, but traditional uses suggest modulation of inflammatory pathways and soothing of mucosal irritations.

Pharmacodynamics

Balsam compounds may influence various biological pathways, contributing to their anti-inflammatory and soothing effects. The aromatic properties can enhance mood and well-being, while topical applications are known to relieve certain skin conditions. The pharmacodynamics in humans, however, require more clinical evidence to fully elucidate their mechanisms.

Pharmacokinetics

The pharmacokinetics of balsam components are not extensively documented, but it is known that the compounds can be absorbed through the skin and mucous membranes. Metabolism primarily occurs in the liver, and elimination is expected to be via urine. However, specific half-lives and clearance rates are not well-studied.

Pregnancy

There is limited information available regarding the safety of balsam during pregnancy. It is advisable to avoid use unless clearly necessary.

Breast-feeding

Due to insufficient data on the excretion of balsam in human milk, caution is advised when using balsam while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• {'name': 'Balsam', 'molecular_formula': 'C15H24', 'description': 'Balsam is a natural resin obtained from various trees, known for its aromatic and medicinal properties. It is often used in topical preparations and alternative medicine.'}

Indications

• Food preservative
• Treatment of urea cycle disorders
• Metabolic disorders involving benzoyl-CoA

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines based on condition.

Adults: Refer to the BNF for specific dosing guidelines based on condition.

Mechanism of action

Benzoate acts mainly by inhibiting the growth of bacteria and fungi through its ability to lower the pH, creating an environment that is less favorable for microbial growth. It is also involved in metabolic pathways where it helps in the conjugation of toxic substances, facilitating their excretion from the body.

Pharmacodynamics

Benzoate is known for its antimicrobial properties, which are particularly effective against a wide range of fungi and bacteria. Its efficacy as a preservative is due to its ability to penetrate microbial cell membranes and disrupt their metabolic processes. Additionally, it has been observed to modulate various metabolic pathways, particularly those associated with aromatic compound degradation.

Pharmacokinetics

After ingestion, benzoate is rapidly absorbed in the gastrointestinal tract. It is metabolized primarily in the liver, where it undergoes conjugation with glycine to form hippurate, which is then excreted in the urine. The half-life of benzoate varies depending on individual metabolic rates but is generally short due to its efficient conversion and excretion.

Pregnancy

There is limited data on the use of benzoate in pregnancy. Consultation with healthcare professionals is advised before use.

Breast-feeding

Limited data is available on the excretion of benzoate in breast milk. Caution is recommended when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Bacterial infections
• Pneumonia
• Meningitis
• Syphilis
• Endocarditis
• Skin and soft tissue infections

Dosage

Children: Paediatric dosing for benzylpenicillin is determined by the child's weight and the severity of the infection. Refer to the BNF for Children for specific dosing guidelines.

Adults: The usual adult dose for benzylpenicillin varies based on the type and severity of the infection. It is generally administered via intramuscular or intravenous routes. For severe infections, doses may range from 1 to 4 million units every 4 to 6 hours.

Mechanism of action

Benzylpenicillin exerts its antibacterial effects by inhibiting the synthesis of bacterial cell walls. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the transpeptidation process, which is crucial for cross-linking peptidoglycan layers. This inhibition leads to cell lysis and death of the bacteria.

Pharmacodynamics

Benzylpenicillin demonstrates time-dependent bactericidal activity, meaning its effectiveness is related to the duration of time the drug concentration remains above the minimum inhibitory concentration (MIC) for the target bacteria. It has a narrow spectrum of activity, primarily targeting Gram-positive cocci and some Gram-negative rods.

Pharmacokinetics

Benzylpenicillin is typically administered parenterally due to poor oral absorption. It is rapidly distributed throughout the body and can penetrate various tissues, including the central nervous system during inflammation. The drug is primarily eliminated by renal excretion, with a half-life of approximately 30 minutes to 1 hour in healthy individuals. Dosage adjustments may be necessary in patients with renal impairment.

Interactions

• leflunomide+benzylpenicillin: Unknown (increases exposure)
• nitisinone+benzylpenicillin: Unknown (increases exposure)
• teriflunomide+benzylpenicillin: Unknown (increases exposure)

Pregnancy

Benzylpenicillin is generally considered safe to use during pregnancy, as it is a penicillin antibiotic and has a long history of use.

Breast-feeding

Benzylpenicillin is excreted in breast milk in small amounts, but it is not expected to have adverse effects on a nursing infant.

Storage

Store in a cool, dry place, protected from light. Reconstituted solutions should be used promptly or stored in a refrigerator and used within a limited time frame.

Formulations

• Benzylpenicillin injection

Mechanism of action

Oxides do not have a single mechanism of action as they are a broad category of compounds. However, in general, metal oxides can exhibit catalytic properties, while non-metal oxides may participate in biochemical reactions by forming acids or bases upon dissolution in water.

Pharmacodynamics

The pharmacodynamics of oxides depend on the specific type of oxide and its interaction with biological systems. For instance, metal oxides may have antimicrobial properties, while certain non-metal oxides can influence metabolic pathways through their acid-base chemistry. The effects vary widely, necessitating specific studies for each oxide's role in therapeutic contexts.

Pharmacokinetics

The pharmacokinetics of oxides are also variable. Many metal oxides are poorly soluble and thus have limited absorption when ingested. Non-metal oxides, such as carbon dioxide, can be readily absorbed and utilized in metabolic processes. The distribution, metabolism, and excretion of oxides depend on their chemical form and the biological system in which they are involved.

Pregnancy

Not applicable as oxide is not a drug but a class of chemical compounds.

Breast-feeding

Not applicable as oxide is not a drug but a class of chemical compounds.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Malaria caused by Plasmodium falciparum
• Malaria caused by Plasmodium vivax
• Severe malaria (as part of combination therapy)
• Fever of unknown origin in endemic areas

Dosage

Children: Refer to specific pediatric guidelines based on age, weight, and clinical status.

Adults: Refer to specific guidelines for dosing, considering individual patient factors such as severity of disease, renal function, and concurrent medications.

Mechanism of action

Quinine acts by interfering with the parasite's ability to metabolize and utilize erythrocyte hemoglobin. It is known to inhibit heme polymerization, which is required for the detoxification of free heme. This leads to the accumulation of toxic heme within the malaria parasite, ultimately resulting in its death. Additionally, quinine has effects on the cardiac muscle by blocking sodium channels and has some antipyretic effects through its action on the hypothalamus.

Pharmacodynamics

Quinine exhibits a dose-dependent reduction in parasitemia and has been shown to increase survival rates in severe malaria cases. It has a long half-life, which allows for once-daily dosing in some situations. Quinine's analgesic and antipyretic effects provide symptomatic relief in febrile conditions. Quinine can cause dose-dependent side effects including cinchonism, which is characterized by tinnitus, headache, and gastrointestinal disturbances.

Pharmacokinetics

Quinine is well absorbed from the gastrointestinal tract and reaches peak plasma concentrations within 1 to 3 hours post-administration. It is extensively metabolized in the liver, primarily by cytochrome P450 enzymes, with a half-life ranging from 10 to 12 hours. The drug is excreted mainly in the urine as metabolites, with a small percentage being eliminated unchanged. Renal impairment can increase the half-life and necessitate dosage adjustments.

Pregnancy

Insufficient data available to establish safety in pregnancy. Consult a healthcare provider for guidance.

Breast-feeding

Limited data on excretion in breast milk; caution is advised. Consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight and moisture.